KM Financial Solutions | Drugmaker Insys wins bankruptcy court approval to sell off opioid
51777
post-template-default,single,single-post,postid-51777,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Drugmaker Insys wins bankruptcy court approval to sell off opioid

Drugmaker Insys wins bankruptcy court approval to sell off opioid

Drugmaker Insys Therapeutics Inc
on Thursday won court approval to sell its flagship
fentanyl spray to a buyer who agreed to only market the drug for
use by cancer patients, in response to concerns about the
product’s role in fueling the opioid epidemic.

No Comments

Sorry, the comment form is closed at this time.